2), a = 5.5503(7) A, b = 7.926(1) A, c = 9.992(1) A, a = 76.891(2)°, P = 89.395(2)°, y = 82.459(2)°, V = 424.3 A 3 , Z = 2, R gl (F) = 0.038, wRrerfF 2 ) = 0.099, T= 100 K.
Source of material
The title compound was synthesized from li/-pyrrolo-[2,3-¿]pyridine via 1-substituted Grignard derivative [1] , Light yellow crystals were grown by slow evaporation from a 95 % ethanol solution at 4 °C.
Discussion
The l//-pyrrolo- [2,3-fc] pyridine derivatives have attracted the attention of chemists in recent years because of their extensive use as gastrointestinal inflammatory disease inhibitor [2] and angiotensin II antagonists [3] . In our synthesis of the substituted 1H-pyrrolo-[2,3-£]pyridines for the bioactive drugs, 2-propyl-l//-pyrrolo-[2,3-fr]pyridine may be prepared with large scale in high yield. To understand the relationship between the structurally endogenous hormone and overall biological property [4] , the crystal structure of the title compound was determined by X-ray singlecrystal diffraction. The purpose of our investigation is to gain better insight into the structure of this molecule.
* Correspondence author (e-mail: zhangqf@ahut.edu.cn)
In the title structure, the overall conformation of the molecule can be described by two torsion angles: C6-C7-C8-C9 [-0.8( 1)°] defines the relative orientation of the side chain towards the aromatic plane, whereas the orientation of propyl group is given by the angle C7-C8-C2-C10 [-177.9 (2) Table 3 . Atomic coordinates and displacement parameters (in A   2 ). 
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